Endovascular mechanical thrombectomy (MT) for the treatment of acute stroke due to large
vessel occlusion has evolved significantly with the publication of multiple positive …

Acute ischaemic stroke is a major public health priority and will become increasingly
relevant to neurologists of the future. The cornerstone of effective stroke care continues to be …

Importance Clinical evidence of the potential treatment benefit of mechanical thrombectomy
for posterior circulation distal, medium vessel occlusion (DMVO) is sparse. Objective To …

The original version of this consensus statement on mechanical thrombectomy was
approved at the European Stroke Organisation (ESO)-Karolinska Stroke Update conference …

卒中是致残和致死的主要疾病之一, 急性缺血性卒中约占全部卒中的80%.
急性缺血性卒中治疗的关键在于尽早开通阻塞血管, 挽救缺血半暗带. 目前被证实有效的急性缺 …

Background Performing mechanical thrombectomy (MT) in patients with basilar artery
occlusion (BAO) is currently not evidence-based. Objective To compare patients' outcome …

Background Evidence supporting a potential benefit of thrombectomy for distal medium
vessel occlusions (DMVOs) of the anterior cerebral artery (ACA) is, to the knowledge of the …

Background: The optimal endovascular strategy for reperfusing distal medium-vessel
occlusions (DMVO) remains unknown. This study evaluates angiographic and clinical …

Ischemic stroke is a predominant cause of disability worldwide, with thrombolytic or
mechanical removal of the occlusion being the only therapeutic option. Reperfusion bears …

Stroke is the second leading cause of death and physical disability, with a global lifetime
incidence rate of 1 in 6. Currently, the only FDA approved treatment for ischemic stroke is the …